ACM
IBB icon

Aviance Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Aviance Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.33M Buy
29,739
+232
+0.8% +$25.4K 0.5% 55
2018
Q4 		$2.85M Sell
29,507
-118,342
-80% -$12.6M 0.4% 61
2018
Q3 		$18M Buy
147,849
+130,040
+730% +$15.3M 1.77% 16
2018
Q2 		$1.96M Buy
17,809
+17,758
+34,820% +$1.9M 0.16% 86
2018
Q1 		$5K Buy
+51
New +$5.65K ﹤0.01% 246
2017
Q4 		– Sell
-20,817
Closed -$2.31M – 296
2017
Q3 		$2.31M Sell
20,817
-777
-4% -$83K 0.16% 84
2017
Q2 		$2.23M Sell
21,594
-18,798
-47% -$1.85M 0.14% 93
2017
Q1 		$3.95M Buy
40,392
+12,885
+47% +$1.23M 0.22% 80
2016
Q4 		$2.43M Sell
27,507
-30,027
-52% -$2.73M 0.13% 92
2016
Q3 		$5.55M Buy
57,534
+12,363
+27% +$1.18M 0.15% 114
2016
Q2 		$3.88M Buy
45,171
+1,377
+3% +$124K 0.12% 113
2016
Q1 		$3.81M Sell
43,794
-20,775
-32% -$1.86M 0.13% 110
2015
Q4 		$7.28M Sell
64,569
-151,401
-70% -$16.4M 0.24% 86
2015
Q3 		$21.8M Buy
+215,970
New +$25.9M 0.77% 40
2015
Q2 		– Sell
-284,274
Closed -$32.5M – 139
2015
Q1 		$32.5M Buy
284,274
+230,826
+432% +$25.5M 1.2% 27
2014
Q4 		$5.4M Buy
53,448
+30,735
+135% +$2.99M 0.19% 92
2014
Q3 		$2.07M Buy
22,713
+9,465
+71% +$831K 0.08% 137
2014
Q2 		$1.14M Sell
13,248
-7,311
-36% -$576K 0.05% 162
2014
Q1 		$1.62M Buy
20,559
+20,091
+4,293% +$1.67M 0.08% 116
2013
Q4 		$35K Sell
468
-84
-15% -$5.96K 0.02% 243
2013
Q3 		$39K Buy
+552
New +$36.2K 0.02% 223

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Aviance Capital Management's IBB Position: Q1 2019 in Review

Aviance Capital Management increased its iShares Biotechnology ETF (IBB) stake by 0.79% in Q1 2019, buying an estimated $25.4K and bringing the position to 29,739 shares worth $3.33M. The position accounts for 0.5% of the portfolio, ranked #55.

Aviance Capital Management first reported a position in IBB in Q3 2013 and has held it in 21 quarters since. The position peaked at $32.5M in Q1 2015. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

  • Aviance Capital Management held 29,739 shares of iShares Biotechnology ETF worth $3.33M as of Q1 2019.
  • Aviance Capital Management bought 232 iShares Biotechnology ETF shares in Q1 2019, an estimated $25.4K.
  • iShares Biotechnology ETF made up 0.5% of Aviance Capital Management's portfolio in Q1 2019, its #55 holding.
  • Aviance Capital Management first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 21 quarters since.
  • Aviance Capital Management's iShares Biotechnology ETF position peaked at $32.5M in Q1 2015.
  • 670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Aviance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.